SomnoMed Dividends and Buybacks
Dividend criteria checks 0/6
SomnoMed does not have a record of paying a dividend.
Key information
n/a
Dividend yield
-41.5%
Buyback Yield
| Total Shareholder Yield | -41.5% |
| Future Dividend Yield | 0% |
| Dividend Growth | n/a |
| Next dividend pay date | n/a |
| Ex dividend date | n/a |
| Dividend per share | n/a |
| Payout ratio | n/a |
Recent dividend and buyback updates
No updates
Recent updates
SomnoMed Limited (ASX:SOM) Stock Catapults 27% Though Its Price And Business Still Lag The Industry
Dec 02
Benign Growth For SomnoMed Limited (ASX:SOM) Underpins Stock's 27% Plummet
Oct 16SomnoMed Limited's (ASX:SOM) Share Price Boosted 30% But Its Business Prospects Need A Lift Too
Jul 15SomnoMed Limited (ASX:SOM) Shares Fly 30% But Investors Aren't Buying For Growth
May 31SomnoMed Limited (ASX:SOM) Stock's 43% Dive Might Signal An Opportunity But It Requires Some Scrutiny
Apr 15SomnoMed (ASX:SOM) Has Debt But No Earnings; Should You Worry?
Mar 04Market Still Lacking Some Conviction On SomnoMed Limited (ASX:SOM)
Dec 21SomnoMed Limited (ASX:SOM) Could Be Riskier Than It Looks
Sep 02Is SomnoMed (ASX:SOM) Using Too Much Debt?
Jun 19It's Unlikely That SomnoMed Limited's (ASX:SOM) CEO Will See A Huge Pay Rise This Year
Nov 18SomnoMed (ASX:SOM) Has Debt But No Earnings; Should You Worry?
Sep 27Is SomnoMed (ASX:SOM) Using Debt Sensibly?
May 10Is SomnoMed (ASX:SOM) Using Debt Sensibly?
Oct 26Health Check: How Prudently Does SomnoMed (ASX:SOM) Use Debt?
May 12Could The SomnoMed Limited (ASX:SOM) Ownership Structure Tell Us Something Useful?
Mar 02Have Insiders Been Buying SomnoMed Limited (ASX:SOM) Shares?
Feb 01
Is SomnoMed (ASX:SOM) Using Debt In A Risky Way?
Dec 28Is SomnoMed Limited (ASX:SOM) Trading At A 38% Discount?
Dec 01Analysts Just Published A Bright New Outlook For SomnoMed Limited's (ASX:SOM)
Jul 28SomnoMed Limited (ASX:SOM) Insiders Increased Their Holdings
Jul 14Stability and Growth of Payments
Fetching dividends data
Stable Dividend: Insufficient data to determine if SOM's dividends per share have been stable in the past.
Growing Dividend: Insufficient data to determine if SOM's dividend payments have been increasing.
Dividend Yield vs Market
| SomnoMed Dividend Yield vs Market |
|---|
| Segment | Dividend Yield |
|---|---|
| Company (SOM) | n/a |
| Market Bottom 25% (AU) | 2.6% |
| Market Top 25% (AU) | 6.2% |
| Industry Average (Medical Equipment) | 1.6% |
| Analyst forecast (SOM) (up to 3 years) | 0% |
Notable Dividend: Unable to evaluate SOM's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.
High Dividend: Unable to evaluate SOM's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.
Earnings Payout to Shareholders
Earnings Coverage: Insufficient data to calculate SOM's payout ratio to determine if its dividend payments are covered by earnings.
Cash Payout to Shareholders
Cash Flow Coverage: Unable to calculate sustainability of dividends as SOM has not reported any payouts.
Discover strong dividend paying companies
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/22 06:29 |
| End of Day Share Price | 2024/12/20 00:00 |
| Earnings | 2024/06/30 |
| Annual Earnings | 2024/06/30 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
SomnoMed Limited is covered by 3 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Russell Wright | APP Securities Pty Ltd. |
| Peter Meichelboeck | Select Equities Pty Ltd |
| Dr Storey | Wilsons Advisory and Stockbroking Ltd. |